IVX Health Hits 10,000 Five-Star Review Milestone Across 160 Centers
National infusion provider IVX Health celebrates a major service milestone as it surpasses 10,000 five-star Google reviews across its 160+ ambulatory infusion…
National infusion provider IVX Health celebrates a major service milestone as it surpasses 10,000 five-star Google reviews across its 160+ ambulatory infusion…
Cleveland Clinic strengthens its Ohio presence by absorbing Youngstown Orthopaedic Associates, integrating specialized musculoskeletal care into its broader regional health system.
Meant enhances its GLP-1 weight care program by combining prescription access with structured care coaching and nutritional support to drive long-term patient…
OrbiMed raises $3 billion for its latest private equity vehicles, underscoring robust institutional demand for healthcare-focused investment strategies in both global and…
HealFast enters the competitive weight loss market, pivoting from its recovery nutrition roots to offer comprehensive telehealth support for metabolic health and…
Vxtra Health founder Larry Hightower details strategies for self-insured employers to gain better control over healthcare costs through improved pricing transparency and…
SenderraRx maintains its specialty pharmacy standing through a renewed ACHC accreditation, highlighting its continued commitment to oncology-focused patient care and operational quality…
DaVita Inc. is set to present seven clinical studies at ASN Kidney Week, underscoring the company's ongoing commitment to nephrology research and…
ECGI Holdings expands its healthcare footprint through the acquisition of Avanta Group, merging specialized provider networks with its proprietary AI-driven strategy.
Owens & Minor strengthens its Halyard portfolio with the release of ARMOR-FLEX sterilization wrap, featuring proprietary technology aimed at enhancing patient safety…
SightMD New York adds Dr. Cecilia Dong to its Flushing location, bolstering the practice's specialized glaucoma and comprehensive ophthalmology care services.
Federal litigation involving GLP-1 medications and NAION diagnoses expands, creating potential mid-term liability risks for industry leaders Novo Nordisk and Eli Lilly.